{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:13:28Z","timestamp":1771334008647,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.actbio.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T12:21:07Z","timestamp":1567686067000},"page":"412-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition"],"prefix":"10.1016","volume":"99","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-2113","authenticated-orcid":false,"given":"Yinsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.09.001_b0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2019.09.001_b0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2019.09.001_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000477851","article-title":"Tumour heterogeneity of breast cancer: from morphology to personalised medicine","volume":"85","author":"Aleskandarany","year":"2018","journal-title":"Pathobiology"},{"key":"10.1016\/j.actbio.2019.09.001_b0020","first-page":"CD003372","article-title":"Single agent versus combination chemotherapy for metastatic breast cancer","volume":"2","author":"Carrick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.actbio.2019.09.001_b0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.actbio.2017.11.010","article-title":"Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy","volume":"66","author":"Liu","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.09.001_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2015.10.022","article-title":"Recent advances of cocktail chemotherapy by combination drug delivery systems","volume":"98","author":"Hu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.09.001_b0035","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bjp.0704365","article-title":"COX-2 and cancer: a new approach to an old problem","volume":"134","author":"Bakhle","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.actbio.2019.09.001_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.actbio.2019.09.001_b0045","first-page":"325","article-title":"Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.actbio.2019.09.001_b0050","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/CMAR.S163747","article-title":"Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures","volume":"15","author":"\u010ceponyt\u0117","year":"2018","journal-title":"Cancer Manage. Res."},{"key":"10.1016\/j.actbio.2019.09.001_b0055","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1158\/0008-5472.CAN-03-3050","article-title":"Celecoxib can prevent tumor growth and distant metastasis in postoperative setting","volume":"64","author":"Roh","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2019.09.001_b0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1535-7163.MCT-10-0415","article-title":"Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis","volume":"10","author":"Xu","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.actbio.2019.09.001_b0065","doi-asserted-by":"crossref","first-page":"38915","DOI":"10.1074\/jbc.M206855200","article-title":"Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2","volume":"277","author":"Patel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2019.09.001_b0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1078-0432.CCR-06-1908","article-title":"Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo","volume":"13","author":"Ponthan","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2019.09.001_b0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejca.2006.09.010","article-title":"Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation","volume":"43","author":"van Wijngaarden","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.actbio.2019.09.001_b0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.msec.2016.11.042","article-title":"Anomalous dissolution behavior of celecoxib in PVP\/Isomalt solid dispersions prepared using spray drier","volume":"72","author":"Ghanavati","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actbio.2019.09.001_b0085","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actbio.2019.09.001_b0090","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2019.09.001_b0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2015.01.001","article-title":"Cancer nanomedicine: from targeted delivery to combination therapy","volume":"21","author":"Xu","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.actbio.2019.09.001_b0100","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/smll.201100436","article-title":"Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics","volume":"7","author":"Shi","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.actbio.2019.09.001_b0105","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7150\/thno.22679","article-title":"Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2019.09.001_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2017.11.002","article-title":"Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal\/photodynamic therapy and chemotherapy","volume":"155","author":"Wan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.09.001_b0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40824-018-0132-z","article-title":"Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications","volume":"22","author":"Uthaman","year":"2018","journal-title":"Biomater. Res."},{"key":"10.1016\/j.actbio.2019.09.001_b0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1076029614551822","article-title":"Efficacy of heparinoid PSS in treating cardiovascular diseases and beyond-a review of 27 years clinical experiences in China","volume":"22","author":"Zeng","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.actbio.2019.09.001_b0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2016.02.063","article-title":"Anticoagulant and antithrombotic activities of low-molecular-weight propylene glycol alginate sodium sulfate (PSS)","volume":"114","author":"Xin","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actbio.2019.09.001_b0130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/jphp.12902","article-title":"Development of an enteric nanoparticle of marine sulfated polysaccharide propylene glycol alginate sodium sulfate for oral administration: formulation design, pharmacokinetics and efficacy","volume":"70","author":"Li","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.actbio.2019.09.001_b0135","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.bmc.2016.07.037","article-title":"Dual and antagonic therapeutic effects of sulfated glycans","volume":"24","author":"Pomin","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actbio.2019.09.001_b0140","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3390\/molecules23102690","article-title":"Unfractionated and low molecular weight heparin reduce platelet induced epithelial-mesenchymal transition in pancreatic and prostate cancer cells","volume":"23","author":"Ponert","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.actbio.2019.09.001_b0145","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/asia.201600452","article-title":"Benzoic-imine-based physiological-pH-responsive materials for biomedical applications","volume":"11","author":"Qu","year":"2016","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.actbio.2019.09.001_b0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-017-0585-2","article-title":"Combination therapy of PKCzeta and COX-2 inhibitors synergistically suppress melanoma metastasis","volume":"36","author":"Zhou","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2019.09.001_b0155","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3748\/wjg.15.4952","article-title":"Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma","volume":"15","author":"Gu","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.actbio.2019.09.001_b0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJN.S124701","article-title":"Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells","volume":"13","author":"Singh","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2019.09.001_b0165","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3892\/ol.2014.2050","article-title":"Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice","volume":"7","author":"Meng","year":"2014","journal-title":"Onco. Lett."},{"key":"10.1016\/j.actbio.2019.09.001_b0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acsnano.6b08244","article-title":"Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions","volume":"11","author":"Anchordoquy","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2019.09.001_b0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nnano.2015.342","article-title":"Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery","volume":"11","author":"Matsumoto","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2019.09.001_b0180","doi-asserted-by":"crossref","first-page":"1605985","DOI":"10.1002\/adfm.201605985","article-title":"A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond","volume":"27","author":"Zeng","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2019.09.001_b0185","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1021\/acs.molpharmaceut.7b00584","article-title":"Nanoparticles of pH-responsive, PEG-doxorubicin conjugates: interaction with an in vitro model of lung adenocarcinoma and their direct formulation in propellant-based portable inhalers","volume":"14","author":"Rao","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.09.001_b0190","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1021\/acsami.8b00875","article-title":"Celecoxib-induced self-assembly of smart albumin-doxorubicin conjugate for enhanced cancer therapy","volume":"10","author":"Shi","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2019.09.001_b0195","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.msec.2019.02.095","article-title":"Derma roller(R) microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect","volume":"99","author":"Ahmed","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actbio.2019.09.001_b0200","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4155\/tde.13.120","article-title":"pH-sensitive drug-delivery systems for tumor targeting","volume":"4","author":"He","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.actbio.2019.09.001_b0205","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.bjc.6602942","article-title":"COX inhibitors and breast cancer","volume":"94","author":"Mazhar","year":"2006","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.actbio.2019.09.001_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000454696","article-title":"Underlying mechanisms for distant metastasis-molecular biology","volume":"33","author":"Pachmayr","year":"2017","journal-title":"Visc. Med."},{"key":"10.1016\/j.actbio.2019.09.001_b0215","first-page":"16","article-title":"Selectins facilitate carcinoma metastasis and heparin can prevent them","volume":"19","author":"Borsig","year":"2014","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.actbio.2019.09.001_b0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fonc.2016.00093","article-title":"Targeting selectins and their ligands in cancer","volume":"6","author":"Natoni","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2019.09.001_b0225","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.phrs.2016.09.037","article-title":"Doxorubicin loaded gold nanoparticles: implication of passive targeting on anticancer efficacy","volume":"113","author":"Dhamecha","year":"2016","journal-title":"Pharmacol. Res."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119306130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119306130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:23:36Z","timestamp":1761672216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119306130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":45,"alternative-id":["S1742706119306130"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.09.001","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}